The DOI matches its Crossref record.
Effects of Electrophysiologic‐Guided Therapy with Class IA Antiarrhythmic Drugs on the Long‐Term Outcome of Patients with Idiopathic Ventricular Fibrillation with or without the Brugada Syndrome
Abstract
Electrophysiologic Drug Testing in Idiopathic VF. Introduction: Implantation of a implantable cardioverter defibrillator (ICD) is viewed universally as the “gold standard” therapy for patients with idiopathic ventricular fibrillation (VF). We sought to study the long‐term value of electrophysiologic (EP)‐guided therapy with Class IA antiarrhythmic drugs in patients with idiopathic VF with or without the Brugada syndrome. Methods and Results: We performed EP studies in 34 consecutive patients who had idiopathic VF with (n = 5) or without (n = 29) the Brugada syndrome. All patients with inducible sustained polymorphic ventricular tachycardia (SPVT) or VF underwent repeated EP evaluation after oral administration of a Class IA antiarrhythmic drug (mainly quinidine). Patients rendered noninducible received this therapy on a long‐term basis. SPVTA/VF were induced in 27 (79.4%) patients at baseline studies. Class IA drugs effectively prevented induction of SPVTA'F in 26 (96%) patients. Of the 23 patients treated with these medications, no patient died or had a sustained ventricular arrhythmia during a mean follow‐up period of 9.1 ± 5.6 years (7 to 20 years in 15 patients). Two deaths occurred in patients without inducible SPVTA'F at baseline studies who had been treated empirically. Conclusion: Our results suggest that EP‐guided therapy with Class IA agents is a reasonable, safe, and effective approach for the long‐term management of patients with idiopathic VF. A randomized prospective study of EP‐guided Class IA therapy in patients with ICDs seems warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
Self-citationAntzelevitch, C., Brugada, P., Borggrefe, M., Brugada, J., Brugada, R., Corrado, D., Gussak, I., LeMarec, H., Nademanee, K., Perez Riera, A. R., et al. (2005) · Circulation · doi:10.1161/01.cir.0000152479.54298.51 · Cited by 1,807
J-Point Elevation in Survivors of Primary Ventricular Fibrillation and Matched Control Subjects
Rosso, R., Kogan, E., Belhassen, B., Rozovski, U., Scheinman, M. M., Zeltser, D., Halkin, A., Steinvil, A., Heller, K., Glikson, M., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.010 · Cited by 566
Self-citationEfficacy of Quinidine in High-Risk Patients With Brugada Syndrome
Belhassen, B., Glick, A., & Viskin, S. (2004) · Circulation · doi:10.1161/01.cir.0000143159.30585.90 · Cited by 494
Self-citationPriori, S. G., Napolitano, C., Gasparini, M., Pappone, C., Della Bella, P., Brignole, M., Giordano, U., Giovannini, T., Menozzi, C., Bloise, R., et al. (2000) · Circulation · doi:10.1161/01.cir.102.20.2509 · Cited by 457
Metadata
- Authors
- BELHASSEN, B., VISKIN, S., FISH, R., GLICK, A., SETBON, I., & ELDAR, M.
- Venue
- Journal of Cardiovascular Electrophysiology
- Publisher
- Wiley
- Published
- 1999-10
- Volume
- 10
- Issue
- 10
- Pages
- 1301-1312
- ISSN
- 1045-3873 (ISSN-L)
- 1540-8167
- OpenAlex
- W1987428270
- Cited by
- 230
- References
- 0
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Electrophysiologic‐Guided Therapy with Class IA Antiarrhythmic Drugs on the Long‐Term Outcome of Patients with Idiopathic Ventricular Fibrillation with or without the Brugada Syndrome. https://app.cochat.ai/papers/10.1111/j.1540-8167.1999.tb00183.x
- The paper
- BELHASSEN, B., VISKIN, S., FISH, R., GLICK, A., SETBON, I., & ELDAR, M. (1999). Effects of Electrophysiologic‐Guided Therapy with Class IA Antiarrhythmic Drugs on the Long‐Term Outcome of Patients with Idiopathic Ventricular Fibrillation with or without the Brugada Syndrome. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/j.1540-8167.1999.tb00183.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.